Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SLO-PHYLLIN

THEOPHYLLINE

Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SLO-PHYLLIN is listed in Drugs@FDA under application 085206 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview SLO-PHYLLIN is listed in Drugs@FDA under application 085206 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.